Rituximab treatment for peripheral ulcerative keratitis associated with Wegener's granulomatosis.
Freidlin
Julie
J
Wong
Ira G
IG
Acharya
Nisha
N
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D003320:Corneal Ulcer / Q000188:drug therapy*; D014890:Granulomatosis with Polyangiitis / Q000150:complications*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab